mk-0616
merck
['cardio']
on the mk-0616 trial findings, dr. says, all doses showed efficacy and demonstrated statistically superior reductions in ldl cholesterol this is encouraging for our phase 3 program which is being designed. #acc23/#wccardio 
The latest news from the American College of Cardiology (ACC) and the 🌎 of cardiovascular health. Follow @ACCinTouch for other ACC updates.